Suchergebnisse - "Ungaro, Ryan C"

PubPharm (150)

61

Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring

enthalten in: Digestive diseases and sciences | 2022

von Gottlieb, Z. | Dolinger, M. | Kayal, M. | +4

62

Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring

enthalten in: Digestive diseases and sciences | 2022

von Gottlieb, Z. | Dolinger, M. | Kayal, M. | +4

63

Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring

enthalten in: Digestive diseases and sciences | 2022

von Gottlieb, Z. | Dolinger, M. | Kayal, M. | +4

64

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients

enthalten in: Journal of Crohn's & colitis | 2022

von Ricciuto, A. | Lamb, C. | Benchimol, E. | +12

65

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease

enthalten in: Digestive diseases and sciences | 2022

von Parekh, R. | Zhang, X. | Ungaro, R. | +4

CommentIn: Dig Dis Sci. 2022 Apr;67(4):1090-1091. - PMID 34181167

66

Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Kayal, M. | Ungaro, R. | Riggs, A. | +12

67

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

enthalten in: Gastroenterology & hepatology | 2022

von Ungaro, R.

68

Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?

enthalten in: Gastroenterology | 2022

von Torres, J. | Ungaro, R. | Colombel, J.

69

Treat to target with ustekinumab for Crohn's disease

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Ungaro, R. | Colombel, J.

CommentOn: Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. - PMID 35120656

70

Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab Concentrations

enthalten in: Inflammatory bowel diseases | 2022

von Ungaro, R. | Colombel, J. | Dubinsky, M. | +2